JAK2 and hematologic disorder: Similar to the UK Biobank, co-occurring JAK2 V617F and 9p CN-LOH (n = 100, OR = 5693 q < 0.001) are consistent with the well-known mechanisms of bi-allelic alterations in specific genes driving the pathogenesis of hematologic malignancies.